Thyrocare Technologies announced that Docon Technologies, promoter of the company, has sold 1,57,69,696 equity shares (9.90% stake) of the company through market trades today, i.e. 13 August 2026.

Consequently, Docon Technologies continues to be a promoter and holding company of Thyrocare Technologies and its holding has reduced from 60.92% to 51.02% of the total paid up equity share capital.